![]() |
市场调查报告书
商品编码
1961089
医疗保健供应链管理市场 - 全球产业规模、份额、趋势、机会、预测:按产品、交付方式、最终用户、地区和竞争对手划分,2021-2031 年Healthcare Supply Chain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Software, Hardware, Services), By Mode of Delivery, By End user, By Region & Competition, 2021-2031F |
||||||
全球医疗保健供应链管理市场预计将从 2025 年的 36.7 亿美元成长到 2031 年的 51.4 亿美元,复合年增长率为 5.76%。
该领域策略性地管理医疗产品、数据和资金从生产商流向最终患者的整个流程。推动这一成长的关键因素包括迫切需要最大限度地降低营运成本,以及日益严格的监管要求,例如加强产品可追溯性和序列化。此外,日益增长的温控生物製药处理量也需要严格的物流管理,这进一步推动了此解决方案的应用。根据医疗保健分销商联盟 (HDA) 预测,到 2024 年,美国药品经销商的销售额将达到 8,620 亿美元,年增 10.4%。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 36.7亿美元 |
| 市场规模:2031年 | 51.4亿美元 |
| 复合年增长率:2026-2031年 | 5.76% |
| 成长最快的细分市场 | 软体 |
| 最大的市场 | 北美洲 |
整合各相关人员分散的资讯科技系统存在巨大的财务和技术障碍,对市场扩张构成重大挑战。许多医疗机构依赖孤立的资料结构,这阻碍了无缝互通性,并限制了整个供应链的透明度。这种缺乏整合的情况常常导致营运效率下降、需求预测不准确,并可能造成严重的库存短缺和系统内过度废弃物。
人工智慧 (AI) 和巨量资料分析在预测性物流领域的应用,正成为全球医疗保健供应链管理市场的主要驱动力。这些技术使相关人员能够透过分析大量资料集来预测需求并优化库存,从而从被动应对模式转向主动策略。借助演算法洞察,企业可以透过精准的库存管理减少营运中断并有效控制废弃物。这项技术进步也体现在基础设施升级;根据医疗保健分销联盟 (HDA) 于 2025 年 9 月发布的第 96 版《概况介绍》,对营运效率的追求正在推动这些技术的应用,68% 的经销商表示他们正在使用自动化解决方案来提高订单准确性和处理速度。
同时,打击假药追踪系统的需求日益增长,成为市场成长的关键决定因素。随着国际贸易网路日趋复杂,製造商必须采用先进的序列化技术,以确保病患安全并遵守严格的法规结构。这种对安全的重视源自于持续不断的非法活动。根据药品安全研究所发布的《2025年报告》,2024年全球将发生6,424起涉毒犯罪案件,凸显了确保供应链安全透明化的迫切性。这种复杂的环境凸显了强大的经销网络的重要性,并有助于主要参与者的财务成功。例如,Cencora在2024年11月公布的财年收入为2,940亿美元,反映了满足此需求所需的庞大物流规模。
整合分散的资讯科技系统所带来的巨大财务和技术挑战,是全球医疗保健供应链管理市场面临的主要阻碍因素。价值链上的各相关人员通常使用互不相容、缺乏互通性的平台,导致资料环境各自独立。这种缺乏整合限制了端到端的可视性,阻碍了准确预测所需的即时资料交换。因此,各组织在优化营运、降低效率以及应对需求波动方面面临许多挑战。
这些技术脱节会导致严重的库存管理失误,直接阻碍市场成长。当资料无法在组织间顺畅流动时,产业将面临更高的缺货和供应中断风险,从而削弱人们对现有管理框架的信心。根据美国系统药剂师协会 (ASHP) 统计,2024 年出现了创纪录的 323 起严重药品短缺事件。这项数据凸显了缺乏一体化供应链基础设施如何限制了确保产品稳定供应的能力,进而阻碍了整体市场发展和管理系统的实施。
向直接病患配送和居家照护模式的转变正在重塑物流网络,将医疗服务地点从集中式医疗机构转移到住宅。这项转变的驱动力在于分散式临床试验的扩展以及对温控生物製药居家给药需求的不断增长,这使得精准的「最后一公里」低温运输能力至关重要。物流供应商正在扩展其基础设施,以支援这些高频次、个人化的患者配送服务。这种策略重组体现在关键业务目标中。根据2025年1月《贝克尔医院评论》发表的报导《UPS医疗保健2025年物流战略内幕》,UPS医疗保健的目标是利用不断增长的居家照护需求,在2026年实现200亿美元的年收入。
同时,致力于永续和环保供应链要求企业透过严格的环境、社会和管治(ESG) 策略来减少对环境的影响。相关人员正积极推动脱碳进程,例如转向电动交通工具、采用可生物降解包装以及优化路线以减少排放。这些努力正逐渐成为衡量企业成功与否的标准指标,与财务绩效并驾齐驱。近期发布的业绩数据也印证了这一行业范围内的努力。根据 Cardinal Health 于 2025 年 2 月发布的 2024 财年环境、社会和管治(ESG) 报告,该公司已成功将其范围 1 和范围 2 的温室气体排放较 2019 年基准值降低了 17%,展现了其在实现碳中和方面取得的切实进展。
The Global Healthcare Supply Chain Management Market is projected to expand from USD 3.67 Billion in 2025 to USD 5.14 Billion by 2031, registering a CAGR of 5.76%. This sector involves the strategic oversight of the movement of medical products, data, and finances from original manufacturers to the end patient. Key drivers of this growth include the critical need to minimize operational expenses and increasing regulatory requirements for enhanced product traceability and serialization. Furthermore, the growing volume of temperature-sensitive biologics necessitates exacting logistics management, which encourages the adoption of these solutions. According to the Healthcare Distribution Alliance, U.S. pharmaceutical distributors achieved $862 billion in sales in 2024, marking a 10.4 percent increase over the prior year.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.67 Billion |
| Market Size 2031 | USD 5.14 Billion |
| CAGR 2026-2031 | 5.76% |
| Fastest Growing Segment | Software |
| Largest Market | North America |
Significant financial and technical barriers related to integrating fragmented information technology systems across various stakeholders pose a major challenge to market expansion. Many healthcare entities rely on siloed data structures that hinder seamless interoperability and restrict visibility across the entire supply chain. This lack of integration frequently leads to operational inefficiencies and inaccurate demand forecasting, which can result in severe inventory shortages or excessive waste within the system.
Market Driver
The incorporation of Artificial Intelligence (AI) and big data analytics into predictive logistics acts as a major catalyst for the Global Healthcare Supply Chain Management Market. These technologies allow stakeholders to shift from reactive models to proactive strategies by examining massive datasets for demand forecasting and inventory optimization. By utilizing algorithmic insights, organizations can reduce operational disruptions and effectively curb wastage through precise stock management. This technological evolution is reflected in infrastructure upgrades; the Healthcare Distribution Alliance's '96th Edition HDA Factbook' from September 2025 notes that the pursuit of operational efficiency has driven widespread technology adoption, with 68 percent of distributors employing automation solutions to improve order accuracy and processing speed.
Concurrently, the growing necessity to combat counterfeit pharmaceuticals via track-and-trace systems is a crucial determinant of market growth. As global trade networks become more intricate, manufacturers are required to implement advanced serialization technologies to ensure patient safety and comply with strict regulatory frameworks. This focus on security is driven by persistent illicit activities; the Pharmaceutical Security Institute reported in 2025 that the sector recorded 6,424 pharmaceutical crime incidents globally during the 2024 calendar year, emphasizing the urgent need for secure supply chain visibility. This complex environment highlights the value of robust distribution networks, contributing to the financial success of key players. For instance, Cencora reported a fiscal year revenue of $294 billion in November 2024, reflecting the massive scale of logistics needed to support these demands.
Market Challenge
The considerable financial and technical difficulties associated with integrating fragmented information technology systems represent a significant restraint on the Global Healthcare Supply Chain Management Market. Stakeholders throughout the value chain often operate on incompatible platforms that lack interoperability, resulting in siloed data environments. This absence of integration restricts end-to-end visibility, preventing the real-time data exchange required for accurate forecasting. Consequently, organizations face challenges in optimizing operations, leading to costly inefficiencies and an inability to respond swiftly to fluctuations in demand.
These technological disconnects directly hinder market growth by causing severe inventory mismanagement. When data fails to flow seamlessly between entities, the industry encounters heightened risks of stockouts and supply disruptions, which undermines confidence in existing management frameworks. According to the American Society of Health-System Pharmacists, the number of active drug shortages hit an all-time high of 323 in 2024. This statistic underscores how the lack of a cohesive supply chain infrastructure limits the ability to ensure consistent product availability, thereby stalling broader market advancement and the adoption of management systems.
Market Trends
The transition toward direct-to-patient and home care delivery models is reshaping logistics networks by moving the point of care from centralized facilities to residential settings. This evolution is driven by the expansion of decentralized clinical trials and the increasing requirement for at-home administration of temperature-sensitive biologics, necessitating precise "last-mile" cold chain capabilities. Logistics providers are subsequently scaling their infrastructure to support these high-frequency, patient-specific shipments. This strategic realignment is highlighted by major operational targets; according to Becker's Hospital Review in January 2025, in the 'Inside UPS' Healthcare 2025 logistics strategy' article, UPS Healthcare is leveraging these expanding home-based service demands to target $20 billion in annual revenue by 2026.
Simultaneously, the focus on sustainable and green supply chain initiatives is compelling organizations to minimize their environmental impact through rigorous Environmental, Social, and Governance (ESG) strategies. Stakeholders are actively decarbonizing operations by transitioning to electric transport fleets, utilizing biodegradable packaging, and optimizing route efficiency to lower emissions. These efforts are increasingly becoming a standard metric of operational success alongside financial performance. This industry-wide commitment is exemplified by recent performance data; according to Cardinal Health in February 2025, in the 'Fiscal 2024 Environmental, Social and Governance (ESG) Report', the company successfully reduced its Scope 1 and 2 greenhouse gas emissions by 17 percent from a fiscal 2019 baseline, reflecting tangible progress toward carbon neutrality.
Report Scope
In this report, the Global Healthcare Supply Chain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Supply Chain Management Market.
Global Healthcare Supply Chain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: